Research Department of Infection and Population Health, UCL, London, UK.
Curr Opin Infect Dis. 2013 Feb;26(1):17-25. doi: 10.1097/QCO.0b013e32835ba6b1.
The life expectancy of people living with HIV has dramatically increased since effective antiretroviral therapy has been available, and still continues to improve. Here, we review the latest literature on estimates of life expectancy and consider the implications for future research.
With timely diagnosis, access to a variety of current drugs and good lifelong adherence, people with recently acquired infections can expect to have a life expectancy which is nearly the same as that of HIV-negative individuals. Modelling studies suggest that life expectancy could improve further if there were increased uptake of HIV testing, better antiretroviral regimens and treatment strategies, and the adoption of healthier lifestyles by those living with HIV. In particular, earlier diagnosis is one of the most important factors associated with better life expectancy. A consequence of improved survival is the increasing number of people with HIV who are aged over 50 years old, and further research into the impact of ageing on HIV-positive people will therefore become crucial. The development of age-specific HIV treatment and management guidelines is now called for.
Analyses on cohort studies and mathematical modelling studies have been used to estimate life expectancy of those with HIV, providing useful insights of importance to individuals and healthcare planning.
自有效抗逆转录病毒疗法问世以来,艾滋病毒感染者的预期寿命显著延长,而且仍在继续提高。在这里,我们回顾了最新的关于预期寿命估计的文献,并考虑了对未来研究的影响。
通过及时诊断、获得各种现有药物和良好的终身依从性,新近感染的人可以预期其预期寿命与 HIV 阴性个体几乎相同。建模研究表明,如果更多地进行 HIV 检测、更好的抗逆转录病毒方案和治疗策略,以及艾滋病毒感染者采用更健康的生活方式,预期寿命可能会进一步提高。特别是,早期诊断是与更好的预期寿命相关的最重要因素之一。生存状况改善的后果是,年龄在 50 岁以上的艾滋病毒感染者人数不断增加,因此,进一步研究老龄化对 HIV 阳性者的影响将变得至关重要。现在需要制定针对特定年龄的 HIV 治疗和管理指南。
对队列研究和数学模型研究的分析被用于估计艾滋病毒感染者的预期寿命,为个人和医疗保健规划提供了重要的有用见解。